GlassScriptPhysician profile
Jenna Prange
NPI 1467695643
$848.76
in general payments reported to CMS, 2019-2025
20 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.82 · 2022: $145 · 2023: $228 · 2024: $93.68 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $124.90 | 2023 | Stelara |
| Regeneron Healthcare Solutions, INC. | $120.35 | 2025 | Evkeeza |
| Pfizer INC. | $86.26 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $79.27 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $75.00 | 2025 | Gemtesa |
| Actelion Pharmaceuticals US, INC. | $62.92 | 2023-2025 | Opsumit, Uptravi |
| Novo Nordisk INC | $39.72 | 2022-2025 | Wegovy |
| Lilly USA, LLC | $29.72 | 2024-2025 | Mounjaro, Zepbound |
| Scynexis, INC. | $28.82 | 2022 | |
| Itamar Medical INC | $27.05 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.68 | 2023 | Invega Sustenna |
| Seqirus USA INC | $23.16 | 2025 | Fluad, Flucelvax |
| Daiichi Sankyo INC. | $21.00 | 2022 | |
| Philips North America LLC | $17.41 | 2024 | (Ck7) Extended Holter |
| Amgen INC. | $16.44 | 2025 | Krystexxa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $16.42 | 2022 | |
| Biogen, INC. | $13.82 | 2021 | |
| Merck Sharp & Dohme LLC | $13.70 | 2025 | M-M-R II, Gardasil 9, Capvaxive |
| Paratek Pharmaceuticals, INC. | $13.63 | 2022 | |
| Sunovion Pharmaceuticals INC. | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Prange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.